Clinical Faculty by Section

Dr. David C. Madoff is Professor of Radiology & Biomedical Imaging, Medical Oncology and Surgical Oncology at Yale School of Medicine. His current administrative roles are Vice Chair for Clinical Research and Section Chief of Interventional Radiology. Dr. Madoff earned his B.A. from Emory University and his M.D. from the University of Pittsburgh. He completed both his internship in Internal Medicine and residency in Radiology at SUNY at Stony Brook and his fellowship training in Vascular and Interventional Radiology at The University of Texas MD Anderson Cancer Center. Dr. Madoff achieved Board Certification in Diagnostic Radiology from the American Board of Radiology in 2000 and attained his Certificate of Added Qualifications in Vascular and Interventional Radiology in 2002. He was a faculty member in the Section of Interventional Radiology at MD Anderson Cancer Center in Houston, Texas for a decade before joining New York-Presbyterian Hospital/Weill Cornell Medical Center in 2011. While at Weill Cornell, Dr. Madoff served as Division Chief of Interventional Radiology from 2011 to 2015 and Vice Chair for Academic Affairs from 2015 to 2019. He moved to Yale in July, 2019. Dr. Madoff has a strong background in clinical care and has treated many patients with complex oncological problems. His clinical interests are wide-ranging, and have included visceral vascular, hepatobiliary and genitourinary interventions, various embolotherapy and percutaneous biopsy techniques and many specialized therapies within the realm of Interventional Oncology. In particular, Dr. Madoff is world-renowned for his work on preoperative portal vein embolization, a technique used to improve the safety of major hepatic resection. This technique is based on the liver's ability to regenerate and has been used in patients with primary and metastatic hepatobiliary cancer to increase the size of the anticipated liver remnant before surgery. Without this procedure, many patients with potentially resectable disease would not be eligible for curative resection. Dr. Madoff is a leader in academic Interventional Radiology and has been an invited speaker at numerous national and international meetings. He authored or co-authored over 200 peer-reviewed scientific articles, has written more than 30 book chapters and served as co-editor of four textbooks including Venous Embolization of the Liver: Radiologic and Surgical Practice (2011), Clinical Interventional Oncology (2014) and Interventional Radiology: Fundamentals of Clinical Practice (2019). Dr. Madoff served as Deputy Editor-in-Chief for the Journal of Vascular and Interventional Radiology from 2007 to 2010 and Deputy Editor for Radiology from 2012 to 2017. Dr. Madoff currently serves as founding co-Editor-in-Chief for Digestive Disease Interventions and on the editorial boards of additional publications that include Techniques in Vascular and Interventional Radiology, Seminars in Interventional Radiology, Cancer Biology & Medicine, Chinese Clinical Oncology and Current Oncology Reports. Dr. Madoff is active in many of the major radiological societies including the Radiological Society of North America, the American Roentgen Ray Society, the Society of Interventional Radiology and the Association of University Radiologists and serves on the Board of Trustees of the American Registry of Radiologic Technologists (ARRT). Based on his important contributions to the field, Dr. Madoff was elected Fellow of the Society of Interventional Radiology in 2007, the American College of Radiology in 2015 and the Cardiovascular and Interventional Radiology Society of Europe in 2018.

Dr. Stacey A. Bass (née Trotter) is an accomplished physician-scientist with extensive training and expertise in diagnostic and interventional radiology, as well as a specialized focus on vascular anomalies. She graduated magna cum laude from Cornell University with a Bachelor of Science in Biology and subsequently pursued her medical and doctoral training through the NIH-supported Medical Scientist Training Program at the University of Virginia School of Medicine. Dr. Bass earned both her MD and PhD, with her doctoral research in neuroscience focusing on epilepsy in an animal model of subcortical band heterotopia. Dr. Bass completed her residency in Diagnostic Radiology at The Johns Hopkins University School of Medicine, where she served as chief resident. She further honed her expertise through a fellowship in Vascular and Interventional Radiology at Johns Hopkins, serving as chief fellow. Following her training, Dr. Bass joined Jefferson Radiology, where she practiced both diagnostic and interventional radiology, rising to the role of Chief of Vascular and Interventional Radiology. During her tenure, she demonstrated exceptional leadership and was elected to the Clinical Governance Board and appointed to the Radiology Partners Interventional Radiology National Advisory Board. Transitioning to academia, Dr. Bass joined the Yale School of Medicine as an Assistant Professor of Vascular and Interventional Radiology and Pediatrics and serves as Medical Director of Pediatric Interventional Radiology. Her leadership expertise has since earned her the role of Co-Chief of Interventional Radiology, Clinical Affi. At Yale, Dr. Bass directs her efforts toward her primary academic and clinical passion: the study, diagnosis, and treatment of vascular anomalies. She founded and directs the Yale New Haven Children's Hospital Vascular Anomalies Program, a globally recognized multidisciplinary group dedicated to advancing care and innovation in this specialized field.

Medical College: The Aga Khan University Medical College.Internship: General Surgery, Yale New Haven Hospital. Residency/Fellowship (IR/DR): Yale New Haven Hospital, Yale University Hobbies and interests: Hiking, playing squash, skiing, cooking and BBQ.General: Before starting Diagnostic/Interventional Radiology residency, I did two years of general surgery (PGY-1/2) at Yale and a year of Burn and Critical Care surgery fellowship at Bridgeport Hospital.

Dr. Chapiro is an Associate Professor in Radiology, Digestive Diseases (Hepatology) and in Biomedical Engineering, Principal Investigator of the Yale Interventional Oncology Research Lab and Director of the Center for Minimally Invasive Therapies. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen with summa cum laude, he served as a postdoctoral research fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin. He joined the Department of Radiology and Biomedical Imaging in 2016 as a research scientist and interventional radiology resident from Berlin, Germany. Dr. Chapiro’s research focuses on developing new quantitative imaging biomarkers for the diagnosis, characterization, and therapeutic management of liver cancer. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence solutions for the management of liver cancer. His basic research interest mainly focuses on developing new tools to characterize the tumor microenvironment and the immune system in the setting of loco-regional, image-guided therapies of liver cancer. Creating innovative and clinically applicable imaging solutions for liver cancer with advanced molecular imaging, image post-processing and machine learning approaches and translating them to clinical practice has been his central mission for the past decade. He authored and co-authored >150 original research articles, reviews and book chapters and gave more than 100 talks and invited lectures within the last seven years. His research has also resulted in several patents, 510(k)-approved medical products and significant grant support from federal, foundational and industry sources. He is an active research mentor to more than 50 undergraduate, medical and graduate students as well as peers both at Yale and other national and international institutions. Being an active contributor, journal-, abstract- and grant reviewer in several professional societies (RSNA, SIR and SIO), he is also committed to education and the mission of disseminating research data and scientific knowledge. Dr. Chapiro consults the Editorial Board of the Journal of Hepatology and Radiology (RSNA), is a member of the American College of Radiology Liver Imaging Reporting and Data System (LI-RADS) Steering Committee, he additionally chairs the Grant Committee of the Society of Interventional Oncology and is the Chair of the Annual Meeting Program Planning Committee for the Subspecialty of Interventional Radiology at the Annual Radiological Society of North America meeting 2021-2023. He is the co-initiator of the "Rising Star" Student Exchange Program in collaboration with the Charité University Hospital in Berlin and directs the Center for Minimally Invasive Therapies. Dr. Chapiro is the Associate Director of the Clinical and Translational Core of the Yale Liver Center.

Dr. Chheang is committed to delivering patient-centered, compassionate care in all fields of interventional radiology. She is Assistant Professor of Radiology and Assistant Director of Informatics. In the latter role, she is actively involved in Yale’s Program for Innovation in Imaging Informatics. She is committed to educating and helping trainees with career development and loves to explore the intersection of technology and healthcare.

Dr. Joshua Cornman-Homonoff is Assistant Professor of Radiology and Biomedical Imaging at the Yale School of Medicine. He earned his BA from Dartmouth College, where he graduated with High Honors in Biology and was inducted into Phi Beta Kappa. He then spent a year at the National Institutes of Health as part of the NIH Academy. During this time, he conducted research focused on the genetics of neural tube defects, and received additional training on healthcare disparities. He received his MD from the University of Pennsylvania, where he completed a dedicated research year studying the epigenetic basis of aging. He then completed an internship in general surgery at Brigham and Women’s Hospital, followed by a residency in diagnostic radiology at NewYork-Presbyterian/Weill Cornell Medical Center. He then underwent additional fellowship training in interventional radiology at Yale-New Haven Hospital, after which he joined the faculty. Dr. Cornman-Homonoff has a particular interest in treating and studying portal hypertension, diseases of the lymphatic system, and venous thromboembolism, among others. Additionally, his departmental roles include focuses on reporting standardization, clinical efficiency, and cost reduction as they apply to interventional radiology. He has authored more than 40 peer-reviewed publications and lectured at numerous conferences.

Dr. Gunabushanam is an Associate Professor of Radiology/Interventional Radiology. He has a special interest in general interventional radiology and vascular ultrasound and interventions. He has been active in numerous national radiology societies including the RSNA, SRU, AIUM and ABR.

Dr. Fabian M. Laage Gaupp graduated from Medical School at Ludwig Maximilians University in Munich and completed his surgical internship at Cornell Presbyterian Hospital in New York. He then pursued residency training in Diagnostic and Interventional Radiology at Yale New Haven Hospital, where he served as Chief Resident of Interventional Radiology. In 2021, he was appointed Assistant Professor of Vascular and Interventional Radiology in Yale's Department of Radiology and Biomedical Imaging. Dr. Laage Gaupp is dedicated to training the next generation of Interventional Radiologists. After serving as Assistant Program Director and Medical Student Clerkship Director for Yale's Interventional Radiology education program for several years, he took over as Interventional Radiology Program Director in 2024. He specializes in minimally invasive treatments for Men’s and Women’s Health, offering innovative solutions for conditions such as benign prostatic hyperplasia (BPH) and uterine fibroids. Through image-guided procedures like prostate artery embolization and uterine fibroid embolization, Dr. Laage Gaupp provides effective, outpatient-based treatment options that eliminate the need for major surgery, allowing patients to return home the same day. As a co-founder of Road2IR, an international consortium led by Yale, Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania, Emory, and other institutions in North America and Europe, Dr. Laage Gaupp has contributed to establishing several Interventional Radiology training programs in East Africa, expanding access to minimally invasive procedures to more patients.

Igor Latich, MD, is an interventional radiologist focused on helping patients—particularly those with cancer—have less pain, improved mobility, and a better quality of life.Dr. Latich specializes in the treatment of degenerative and tumor-related musculoskeletal and spine disease with a particular focus on pain management.  “My primary focus is clinical care and development of new service lines within interventional radiology, such as orthopaedic interventions, endoscopic-guided interventions and laser-assisted biliary stone management, and improvement to existing pain and palliative service lines,” he says. “I enjoy how my job allows me to interact with patients while providing minimally invasive treatments for complex disease processes. I tell patients I will never give up on them.” His research interests span the world of interventional orthopaedics (development of novel percutaneous methods for acetabular stabilization in metastatic disease), biliary interventions (development of solutions for percutaneous sclerosis of the gallbladder mucosa in non-operative patients with cholecystitis), and quality improvement (development of anti-coagulation guidelines to rationalize the use of reversal agents).  Dr. Latich is actively involved in diagnostic radiology and interventional radiology trainee and medical student education and serves on the medical school admissions committee.

Dr. Lee is an Assistant Professor of Radiology & Biomedical Imaging at the Yale School of Medicine. She earned her BA at Stanford University and received her MD from Washington University in St. Louis. She completed her diagnostic radiology residency at the Mallinckrodt Institute of Radiology, where she also completed her Interventional Radiology fellowship training. Sheis board certified by the American Board of Radiology and is a diplomate in Interventional Radiology/Diagnostic Radiology.Dr. Lee performs a full spectrum of minimally invasive, image-guided procedures with a special interest in prostate interventions including prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH), MR-guided ablation of the prostate via the urethra (TULSA) for prostate cancer, MR-guided prostate biopsies, and uterine fibroid embolization (UFE).Dr. Lee currently serves as the Associate Program Director for Yale's Interventional Radiology Residency programs.

Dr. Marino is an Assistant Professor of Radiology & Biomedical Imaging at the Yale School of Medicine. He attended medical school at the New York College of Osteopathic Medicine and completed both his Diagnostic Radiology residency and Vascular & Interventional Radiology fellowship at Yale-New Haven Hospital.Dr. Marino is a board-certified Interventional Radiologist, who performs minimally invasive, image-guided procedures in almost every part of the body. These procedures utilize X-ray, ultrasound, CT scans and MRI to guide catheters and needles to deliver targeted treatments. Complex conditions can be treated via tiny incisions, affording patients shorter recovery times with less pain and lower risk compared to open surgery. While practicing all aspects of Vascular & Interventional Radiology, Dr. Marino’s current clinical interests and expertise focus on venous disease, including treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), inferior venacava filter retrieval, central venous and iliocaval reconstruction, varicose and spider veins, vascular abnormalities, and hemodialysis access maintenance, including percutaneous endovascular fistula creation. To schedule an appointment, please call 203-785-4747.

Hamid Mojibian, MD, is director of cardiac CT/MR Imaging for Yale Medicine’s Department of Radiology & Biomedical Imaging.He and a team of radiologists and cardiologists perform cardiac imaging studies to detect heart problems such as coronary artery disease. In his role, Dr. Mojibian also performs minimally invasive interventional cardiac procedures such as thrombectomy to remove pulmonary embolisms. It’s a new procedure in which he inserts a device into the veins to the pulmonary artery that can remove blood clots blocking normal airflow to the lungs that cause the right side of the heart to fail. “Patients come to us in a very dire situation and leave almost normal,” he says. The nonsurgical procedure can be done in an hour or two and is done through a small hole in the groin, leaving no scar. “It feels amazing that we can provide immediate, life-changing care for patients.” Dr. Mojibian also performs a variety of other interventional procedures such as creating AV fistulas for dialysis using a safe, nonsurgical, outpatient technique. He enjoys working with referring cardiologists and nephrologists because providing the highest quality care, he says, requires dedicated teamwork.

Juan Carlos Perez Lozada, MD, is an interventional radiologist who says he enjoys the minimally invasive aspect of his work that allows patients to recover rapidly.“The extensive variety of pathology each day makes this field my passion,” Dr. Perez Lozada says. “My favorite part of interventional radiology is the scope and breadth of clinical conditions and procedures that I can treat and the constant innovation of my field. I love that I still am able to guide and counsel patients in clinic and be part of their treatment team.” He says he always lets his patients know that their well-being is his priority. “I want them to be safe regardless of the procedure. I want the best treatment possible regardless of the specialty that will take care of them,” he says. “The best patient is the one that has knowledge of their options.” Dr. Perez Lozada offers uterine fibroid embolization, spine interventions, pain management and nerve blocks, dialysis interventions, management of deep venous thrombosis and pulmonary embolism, and interventional oncology.

Dr. Pollak went to medical school at the Columbia University College of Physicians & Surgeons and subsequently did his Diagnostic Radiology residency at the Columbia-Presbyterian Medical Center. His fellowship in Vascular & Interventional Radiology was at the Hospital of the University of Pennsylvania. He then joined the Yale University School of Medicine Department of Radiology and Biomedical Imaging in the section of V&IR and served as the section chief and director of the fellowship program in this sub-specialty for over two decades. While active in all aspects of vascular & interventional radiology, his current major interests are embolotherapy (embolization), including for acquired and congenital vascular abnormalities and malformations (other than in the brain), fibroids, and malignancies, as well as other minimally invasive treatments for tumors, including local ablation. In addition, he is an expert in vascular procedures in the liver, such as intrahepatic portosystemic shunts and venous procedures, such as inferior vena cava filters. Dr. Pollak is the current director of the multidisciplinary Yale Hereditary Hemorrhagic Telangiectasia Program, which was started as the first of its kind in the world in the early 1990s. As such, he has extensive experience in the evaluation and management of patients with this genetic disorder, with particular expertise in embolization of pulmonary arteriovenous malformations, which frequently occur in this population. Dr. Pollak is also the co-director of the Yale Pulmonary Embolism Response Team, a multidisciplinary group of physicians interested in the advancement of the management of patients with this condition, especially those with more severe manifestations.

Dr. Schlachter is an Assistant Professor of Radiology and Biomedical Imaging at the Yale School of Medicine.Dr. Schlachter's research interests include: Liver Cancer and diseases involving the liver.Dr. Schlachter completed his surgical intern year at the University of Pennsylvania School of Medicine and his Radiology Residency from the University of Connecticut School of Medicine. After finishing his Interventional Radiology fellowship at Johns Hopkins School of Medicine in 2012, he was hired as an Attending where he focused on treating a wide range of vascular diseases including liver cancer. Dr. Schlachter is committed to working together to determine the most effective treatments for his patients.

Doug Silin, MD is the Interventional Radiology Residency Program Director and responsible for the education of the next generation of interventional radiologists at Yale New Haven Hospital.Dr Silin is a native of greater Boston and a Bruins fan. He graduated from Dartmouth college with a degree in Computer Science. He worked as a consultant t for Digital Equipment Corporation after college and continued consulting while competing is MD at Boston University. After an internship in Baltimore, he completed a residency in Massachusetts and s fellowship at Yale.After completing his training, he moved to Indiana for nine years and developed an interventional radiology practice at Ball Memorial Hospital. However, in 2005 he returned to New Haven with his wife, a hematopathologist, and his three children.Dr Silin has been an innovator in interventional radiology with two patents, many speaking engagements, and several research papers. He has a strong passion for education and global outreach and a clinical interest in complex percutaneous procedures.

Dr. Zuckerman has been in practice for over 30 years, specializing in interventional radiology. Nearly his entire career has been spent in academic medicine participating in the training of residents, fellows, and students as well as clinical research; he is the author or co-author of several dozen peer-reviewed manuscripts and has been site primary investigator in a number of multicenter clinical trials. Active in organized radiology on the national level, he currently chairs the exam development committee of the American Board of Radiology.